Stock listing

Curis, Inc.

Selected listing: CUS0 · HAM · EUR · DE

Curis, Inc. (Hamburg:CUS0), Health Technology. Latest release Aug 13, 2026: Curis, Inc. Announces Pricing of $5.6 Million Public Offering.

CUS0:HAMEURDEUpdated September 25, 2026

Ticker: Hamburg:CUS0
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Hamburg
Currency: EUR

About Curis, Inc.

Curis, Inc. (ticker: CRIS) is a public company operating in the American market. The company is dedicated to advancing its pipeline of drug candidates to address unmet medical needs in oncology.

Latest news from Curis, Inc.

Curis, Inc. Announces Pricing of $5.6 Million Public Offering

August 13, 2026

Curis Doses First Five Patients in TakeAim CLL Study

July 30, 2026

Curis Announces Positive Emavusertib Update

July 22, 2026

Curis Consents First Six Patients in TakeAim CLL Study

July 6, 2026

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

June 26, 2026

All Curis, Inc. news →

Events

Replays

Curis, Inc. (CRIS) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:30 PM ET
Watch
Curis, Inc. (CRIS) Q4 2025 Earnings Call
Thu, Mar 19, 2026 · 04:30 PM ET
Watch
Curis, Inc. (CRIS) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 04:30 PM ET
Watch

Research Curis, Inc.

Curis, Inc. company profile

View the public company page for Curis, Inc. on 6ix.

Curis, Inc. news

Read company news and market updates connected to Curis, Inc..

Curis, Inc. investor events

Find investor webinars, events, and replay context for Curis, Inc..